Amgen Compound definition

Amgen Compound means the Amgen small molecule methylthioadenosine cooperative protein arginine methyltransferase 5 (PRMT5) inhibitor known as AMG 193, including any metabolites, prodrugs, isomers, enantiomers, esters, salts, hydrates, solvates, or polymorphs thereof, and any drug candidate or product containing any of the foregoing as the sole active ingredients.
Sample 1
Amgen Compound means a PDE10 inhibitor or modulator, other than a Primary Compound or Secondary Compound, (a) for which Amgen during the Agreement Term has rights, whether by reason of its own conception of such inhibitor or modulator, or under agreement with a Third Party, and (b) was not identified or confirmed as a PDE10 inhibitor or modulator through the use of the Memory Screening Technology. All rights in and to any Amgen Compound shall remain solely owned by Amgen, and Memory shall have no rights, and Amgen shall have no obligations, financial or otherwise, to Memory, under this Agreement with respect to any Amgen Compound.
Sample 1
Amgen Compound means the Initial Compound, and each other Amgen proprietary pharmaceutical compound or other product in existence on the Effective Date or developed after the Effective Date for treatment of any indication in the Licensed Field or the Option Field, and associated know-how.
Sample 1

Examples of Amgen Compound in a sentence

  • During the term of the Agreement, within thirty (30) days after determination by Amgen that any compound meets the definition of an Amgen Compound, NPS/Amgen Compound or Third Party Compound, such compound shall be designated by Amgen as an Amgen Compound, NPS/Amgen Compound or Third Party Compound, as the case may be.

  • The Pharmacovigilance Agreement will include safety data exchange procedures governing the coordination of collection, investigation, reporting, and exchange of information concerning adverse experiences, pregnancy reports, and any other safety information arising from or related to the use of the Ideaya Compound and the Amgen Compound in the Study, consistent with Applicable Law and in accordance with the terms of the Pharmacovigilance Agreement.

  • Bioject hereby grants to Amgen for the Term a right of first offer to obtain an exclusive worldwide license under the Licensed Patents and the Bioject Intellectual Property to use the Iject System for any Amgen Compound in the Option Field, as the Iject System may be modified from time to time to deliver any Amgen Compound as mutually agreed by Bioject and Amgen.

  • If Amgen receives any comments or other inquiries from a Regulatory Authority that pertain to the Combination (other than solely to the Amgen Compound) or that pertain to the Ideaya Compound (including in the Combination), Amgen will promptly provide such comments and/or inquiries to Ideaya, subject to Amgen’s right to redact any Third Party proprietary information or information relating to other Amgen compounds.

  • Notwithstanding Section 10.1 (Joint Ownership and Prosecution), the Parties agree that all rights to Inventions to the extent relating solely to the Ideaya Compound, including any novel method-of-treatment and use involving the Ideaya Compound (and not the Amgen Compound), are the sole and exclusive property of Ideaya (the “Ideaya Sole Inventions”) and Amgen hereby assigns and agrees to assign all rights therein to Ideaya.

  • All rights in and to any Amgen Compound shall remain solely owned by Amgen, and Memory shall have no rights, and Amgen shall have no obligations, financial or otherwise, to Memory, under this Agreement with respect to any Amgen Compound.

  • Subject to Sections 10.2 (Inventions Owned by Amgen) and 10.3 (Inventions Owned by Ideaya), all rights to all Inventions, including any Inventions relating to or covering the combined use of the Amgen Compound and the Ideaya Compound (each a “Jointly Owned Invention”) will belong jointly to Amgen and Ideaya.

  • Notwithstanding the restrictions in this Section 11.3, no provision of this Agreement shall be deemed to restrict Amgen's ability to assign, license or otherwise transfer to any third party any or all of its rights in or to any Amgen Compound.

  • Such vendor will provide the processed results of their bioanalytical work of such Samples to Amgen, a summary of which processed results will be included in the Final Study Report or similar report, along with the bioanalytical work of the Ideaya Compound and Amgen Compound performed by or on behalf of Amgen.

  • For the avoidance of doubt, any Invention generically encompassing the Amgen Compound (and not the Ideaya Compound) within its scope, even where such Amgen Compound is not disclosed per se, is the exclusive property of Amgen.

Related to Amgen Compound

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Exempt compound means the same as defined in Rule 2.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • X-ray field means that area of the intersection of the useful beam and any one of the set of planes parallel to and including the plane of the image receptor, whose perimeter is the locus of points at which the exposure rate is one-fourth of the maximum in the intersection.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Generic Product means any pharmaceutical product that (i) is sold by a Third Party that is not an Affiliate or licensee of Buyer and (ii) (a) contains the same active pharmaceutical ingredient as the Product or (b) is categorized by the applicable Governmental Entity in a country to be therapeutically equivalent to, or interchangeable with, the Product, such that the pharmaceutical product may be substituted for the Product at the point of dispensing without any intervention by the prescribing physician in such country.

  • Alternative nicotine product means any vaping product, whether or not it includes nicotine, including electronic smoking devices, that can be ingested into the body by chewing, smoking, absorbing, dissolving, inhaling, or by any other means. ‘Alternative nicotine product’ does not include: